Skip to Main Content

Paper Details

Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients.
Front Med (Lausanne)
2
2022
Author NameAffiliation
Yu-Han Kao
Chetan BettegowdaThe Howard Hughes Medical Institute, The Johns Hopkins Kimmel Cancer Center
Chetan BettegowdaThe Johns Hopkins University School of Medicine
Joshua T VogelsteinInstitute for Computational Medicine, The Johns Hopkins University
Joshua T VogelsteinBloomberg School of Public Health, The Johns Hopkins University
Joshua T VogelsteinInstitute for Computational Medicine, The Johns Hopkins University
Joshua T VogelsteinBloomberg School of Public Health, The Johns Hopkins University
Nickolas PapadopoulosThe Howard Hughes Medical Institute, The Johns Hopkins Kimmel Cancer Center
Nickolas PapadopoulosThe Johns Hopkins University School of Medicine
Rong Chen
Rong ChenThe Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Eric E Schadt
Eric E Schadt
Eric E SchadtThe Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Eric E SchadtThe Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
William K Oh
William K OhIcahn School of Medicine at Mount Sinai
  • 1 - 17

Datasets

Release 1.2